A unique industry-led meeting focusing on accelerating the development & commercialisation of innovative dermatological medicines
The dermatology space continues to strive in therapeutic innovation; driven by a transformative evolution in the understanding of the pathophysiology of skin diseases and the availability of treatment options for conditions that affect the lives of millions of patients worldwide. This vast environment of opportunity is driving leading organisations and experts to focus on innovating and bringing better and more efficient therapies to market.
Expanding on two editions of the annual US meeting, the Dermatology Drug Development series makes its debut in Frankfurt to provide the European dermatology community with an end-to-end industry forum dedicated to bringing new dermatological medicines to market.
Join this growing platform to gain exclusive insights from experts, collaboratively tackle challenges being faced to develop these drugs and uncover the details behind the latest developments in this space.
View full event guide for more information.
"Thanks for putting together a great conference! It was beneficial to bring together experts from academia, industry and health authorities."
"All of the speakers did a great job. This was really a good conference - both size-wise and the quality of attendees."
"Meeting was well organised. Content was very rich. Networking was excellent."
BASF Pharma Solutions
Key Benefits of Attending:
Hear from 20 Expert Speakers including:
Executive Vice President & CSO
Vice President & Head of Medical Affairs Immuno Inflammation
Vice President - Translational Sciences
President - Worldwide Markets, Inflammation & Immunology
Vice President of Dermatology